A detailed history of Eastern Bank transactions in Novartis Ag stock. As of the latest transaction made, Eastern Bank holds 92,566 shares of NVS stock, worth $9.25 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
92,566
Previous 171,947 46.17%
Holding current value
$9.25 Million
Previous $19.8 Million 54.46%
% of portfolio
0.17%
Previous 0.36%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$96.78 - $117.18 $7.68 Million - $9.3 Million
-79,381 Reduced 46.17%
92,566 $9.01 Million
Q3 2024

Oct 21, 2024

BUY
$106.13 - $120.89 $18.2 Million - $20.8 Million
171,947 New
171,947 $19.8 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.